Compounds > isoniazid
Page last updated: 2024-10-29

isoniazid and Communicable Diseases

isoniazid has been researched along with Communicable Diseases in 15 studies

Hydra: A genus of freshwater polyps in the family Hydridae, order Hydroida, class HYDROZOA. They are of special interest because of their complex organization and because their adult organization corresponds roughly to the gastrula of higher animals.
hydrazide : Compounds derived from oxoacids RkE(=O)l(OH)m (l =/= 0) by replacing -OH by -NRNR2 (R groups are commonly H). (IUPAC).

Communicable Diseases: An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or human host.

Research Excerpts

ExcerptRelevanceReference
"Currently, no information is available on the effect of resistance/susceptibility to first-line drugs different from isoniazid and rifampicin in determining the outcome of extensively drug-resistant tuberculosis (XDR-TB) patients, and whether being XDR-TB is a more accurate indicator of poor clinical outcome than being resistant to all first-line anti-tuberculosis (TB) drugs."3.74Clinical and operational value of the extensively drug-resistant tuberculosis definition. ( Besozzi, G; Cirillo, DM; Codecasa, LR; Ferrara, G; Girardi, E; Gori, A; Kliiman, K; Lange, C; Matteelli, A; Migliori, GB; Raviglione, MC; Spanevello, A; Toungoussova, OS, 2007)
"Isoniazid (INH) is a key element of the first line anti tuberculosis treatment regimen."1.51Use of nanotechnology for infectious disease diagnostics: application in drug resistant tuberculosis. ( Adikaram, CP; De Silva, KMN; Karunaratne, RE; Perera, J; Wijenayaka, LA; Wijesundera, SS, 2019)

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-199012 (80.00)18.7374
1990's0 (0.00)18.2507
2000's1 (6.67)29.6817
2010's1 (6.67)24.3611
2020's1 (6.67)2.80

Authors

AuthorsStudies
Al-Khattaf, FS1
Mani, A1
Atef Hatamleh, A1
Akbar, I1
Karunaratne, RE1
Wijenayaka, LA1
Wijesundera, SS1
De Silva, KMN1
Adikaram, CP1
Perera, J1
LEVADITI, C1
VAISMAN, A1
CHAIGNEAU-ERHARD, H1
BOUR, H1
DUCOMET, JC1
BRETON, A2
GAUDIER, B2
PIERRET, R2
WERNER, E1
PHILIPP, H1
ZIESCHE, K1
FRADKIN, VA1
PALACIOS, E1
GUSEV, VA1
LOWE, CR1
PELTOKALLIO, P1
PELTOKALLIO, V1
ENTZ, A1
FOSSATI, C1
KAWAGUCHI, Y1
Migliori, GB1
Besozzi, G1
Girardi, E1
Kliiman, K1
Lange, C1
Toungoussova, OS1
Ferrara, G1
Cirillo, DM1
Gori, A1
Matteelli, A1
Spanevello, A1
Codecasa, LR1
Raviglione, MC1

Other Studies

15 other studies available for isoniazid and Communicable Diseases

ArticleYear
Antimicrobial and cytotoxic activities of isoniazid connected menthone derivatives and their investigation of clinical pathogens causing infectious disease.
    Journal of infection and public health, 2021, Volume: 14, Issue:4

    Topics: Anti-Infective Agents; Communicable Diseases; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria;

2021
Use of nanotechnology for infectious disease diagnostics: application in drug resistant tuberculosis.
    BMC infectious diseases, 2019, Jul-12, Volume: 19, Issue:1

    Topics: Antitubercular Agents; Bacterial Proteins; Catalase; Communicable Diseases; DNA, Bacterial; Gold; Hu

2019
[Curative action of isonicotinic acid hydrazide (INH) on infection induced in the mouse by strain 607 of Mycobacterium paratuberculosis].
    Annales de l'Institut Pasteur, 1953, Volume: 84, Issue:3

    Topics: Animals; Communicable Diseases; Isoniazid; Mice; Mycobacterium; Mycobacterium avium subsp. paratuber

1953
[Does isoniazid change the prognosis of primary infection in its pulmonary lymph node form?].
    Pediatrie, 1955, Volume: 10, Issue:8

    Topics: Aminosalicylic Acid; Child; Communicable Diseases; Humans; Infant; Isoniazid; Lymph Nodes; Niacin; N

1955
[Incidence of resistance of Koch bacillus to antibiotics during primary infection].
    Archives francaises de pediatrie, 1956, Volume: 13, Issue:6

    Topics: Aminosalicylic Acid; Anti-Bacterial Agents; Antibiotics, Antitubercular; Bacillus; Child; Communicab

1956
[Incidence of resistance of Koch bacillus to antibiotics during primary infection].
    Archives francaises de pediatrie, 1956, Volume: 13, Issue:6

    Topics: Aminosalicylic Acid; Anti-Bacterial Agents; Antibiotics, Antitubercular; Bacillus; Child; Communicab

1956
[Incidence of resistance of Koch bacillus to antibiotics during primary infection].
    Archives francaises de pediatrie, 1956, Volume: 13, Issue:6

    Topics: Aminosalicylic Acid; Anti-Bacterial Agents; Antibiotics, Antitubercular; Bacillus; Child; Communicab

1956
[Incidence of resistance of Koch bacillus to antibiotics during primary infection].
    Archives francaises de pediatrie, 1956, Volume: 13, Issue:6

    Topics: Aminosalicylic Acid; Anti-Bacterial Agents; Antibiotics, Antitubercular; Bacillus; Child; Communicab

1956
[On ambulant INH longterm therapy. Part III. Infectious hygiene results].
    Beitrage zur Klinik der Tuberkulose und spezifischen Tuberkulose-Forschung, 1960, Volume: 121

    Topics: Communicable Diseases; Hygiene; Isoniazid

1960
[The reaction of neutrophil blood cell as an indication of infectious and drug allergy].
    Allergie und Asthma, 1962, Volume: 8

    Topics: Communicable Diseases; Drug Hypersensitivity; Humans; Isoniazid; Leukocytes; Neutrophils; Streptomyc

1962
[NEUROLOGIC COMPLICATIONS OF INFECTIOUS DISEASES].
    Revista chilena de pediatria, 1963, Volume: 34

    Topics: Adrenocorticotropic Hormone; Child; Communicable Diseases; Humans; Immunization; Infant; Isoniazid;

1963
[TREATMENT OF MENINGEAL TUBERCULOSIS IN PREGNANT WOMEN].
    Problemy tuberkuleza, 1963, Volume: 41

    Topics: Aminosalicylic Acid; Aminosalicylic Acids; Cesarean Section; Communicable Diseases; Cortisone; Femal

1963
CONGENITAL DEFECTS AMONG CHILDREN BORN TO WOMEN UNDER SUPERVISION OR TREATMENT FOR PULMONARY TUBERCULOSIS.
    British journal of preventive & social medicine, 1964, Volume: 18

    Topics: Abnormalities, Drug-Induced; Aminosalicylic Acid; Aminosalicylic Acids; Communicable Diseases; Conge

1964
THE SIGNIFICANCE OF LIVER NEEDLE BIOPSY IN THE DIAGNOSIS OF TUBERCULOSIS.
    Acta tuberculosea et pneumologica Scandinavica, 1964, Volume: 43

    Topics: Aminosalicylic Acid; Aminosalicylic Acids; Biopsy; Biopsy, Needle; Communicable Diseases; Diagnosis;

1964
[EXPERIENCES IN THE TREATMENT OF VIRAL HEPATITIS IN TUBERCULOUS PATIENTS].
    Tuberkulozis es tudobetegsegek, 1963, Volume: 16

    Topics: Adrenal Cortex Hormones; Communicable Diseases; Cycloserine; Drug Therapy; Hepatitis; Hepatitis A; I

1963
[PROPHYLAXIS WITH ISONIAZID DURING PREGNANCY AND PUERPERIUM TO PREVENT THE REACTIVATION OF INACTIVE TUBERCULAR FOCI].
    Gazzetta medica italiana, 1964, Volume: 123

    Topics: Communicable Diseases; Drug Therapy; Female; Humans; Isoniazid; Postpartum Period; Pregnancy; Pregna

1964
[Relation between host resistance and disease type in leprosy. 7. Effects of chemotherapy in primary infection on leproma development in superinfection in benign murine leprosy].
    Nihon saikingaku zasshi. Japanese journal of bacteriology, 1962, Volume: 17

    Topics: Actinomycetales Infections; Animals; Communicable Diseases; Humans; Isoniazid; Leprosy; Mice; Superi

1962
Clinical and operational value of the extensively drug-resistant tuberculosis definition.
    The European respiratory journal, 2007, Volume: 30, Issue:4

    Topics: Antitubercular Agents; Communicable Diseases; Drug Resistance, Multiple; Extensively Drug-Resistant

2007